Blog | Veristat Insights

In 1964, a child’s chance of surviving the most common form of Leukemia was 3%.  Today it has increased to 91%!  

With the summer in full swing, vacations and long weekends by the pool are top of mind.

Although we all have the best intentions to use our paid time off each year, it is also not a secret that Americans are truly terrible at taking time off.  According to Project: Time Off, 52% of American employees reported having unused vacation days at the end of 2017.

Have you ever tried to paint a room in the dark? Probably not, right? 

Why would anyone go through the trouble of getting the supplies and putting in the effort to attempt a job well done if they couldn’t see their progress along the way?  Just the same, why would anyone turn their career over to the annual performance review process? 

With the holiday season in full swing, it’s hard not to reflect on this past year and realize how thankful Veristat is to play such an instrumental role in the world of clinical research.  

Veristat aspires to make a difference, every day!  

As the weather gets colder and we find ourselves in the holiday season, the employees of Veristat decided to make a difference by helping others in their local communities.   

On Thursday, March 2, Veristat was buzzing with excitement as it officially opened its new office in Morrisville, NC.

One of the many perks at Veristat is that employees are encouraged to take a paid Day of Service every year to spend time volunteering and giving back to their surrounding community.    We believe that part of making a difference in the world means making the time to help others.  

For anyone who follows this blog with even moderate consistency, it is probably clear that Veristat is a growing organization.  It is hopefully just as apparent that we are a group who tremendously values and fiercely protects our culture. 

This Holiday Season, Veristat is continuing its tradition of participating in the Movement to Beat Rare Cancers!

On behalf of all of our clients, Veristat has made a $12,500 donation to one of the many organizations that we supported this year and will support in 2017, Cycle for Survival.

Just last week, in the midst of the daily chaos of building new clinical trial databases, working on impending regulatory submissions, holding project team meetings, and programing tables figures & listings, Veristat paused its operations for one day in order to reflect upon and celebrate its contributions to drug development.